Smart

 
 
 
 

Microban International is delighted to announce its attendance and participation in this year’s Foam Expo North America, taking place June 28-30. The global leader in antimicrobial treatments will have a dedicated booth on the expo floor, where it will showcase its various solutions for foam products, demonstrating how far these technologies have come since their inception, with older formulations giving way to a newer generation of more environmentally friendly additives.

Lithuanian capital Vilnius has set goals to promote car-sharing, increase sustainable travels, and reduce the number of cars in the city by urging residents to swap their personal vehicles with shared ones. As a car-sharing leader in Europe, the city cooperated with the city’s businesses to form a mobility cluster—Vilnius Shared Mobility Hub.

When producing a product, prototyping is key. Before scaling up you must test, refine, and gather market feedback to create the best possible product for your customers. The problem is prototyping can be time-consuming, expensive, and challenging for high throughput, high yield production.

Japanese automotive industry gets a new operator as the Finnish self-driving company opens an office in Tokyo. Sensible 4’s autonomous driving technology is known for its ability to work in challenging weather conditions. Also, Sensible 4’s autonomous shuttle bus designed by MUJI does piloting in Chiba, Japan.

Since the launch of the world's first smog-reducing shingle, Malarkey Roofing Products has provided the industry with enough roofing materials to protect more than 400,000 roofs. Because each roof has the smog-fighting capacity of two to three trees, that's the equivalent of over 1 million trees of smog-reducing power.

Merck is expanding its membrane and filtration manufacturing capabilities in Ireland. The company will invest approximately €440 million.

Company to invest in two major Life Science projects over five years
Significantly increases membrane manufacturing capacities and enables construction of new filtration manufacturing facility
Supports Merck’s strategy to invest in products and technologies across its portfolio that are key to manufacturing novel therapies, vaccines and diagnostics
Investment creates more than 370 jobs by the end of 2027

Meet Our Sponsors

Latest Sponsor News

Articles Most Read

Latest News

Statistics

Articles View Hits
794938

Who's Online

We have 36 guests and no members online